NanoValent Pharmaceuticals is a privately-held company based in Bozeman, MT, specializing in the development of a unique TARGETED NANOSPHERE (TNS) platform. Their innovative product candidates have the potential to significantly enhance the delivery, safety, and performance of cancer and other therapeutics, both existing and emerging.
Collaborating closely with Children's Hospital Los Angeles (CHLA) and other academic partners in the US, NanoValent Pharmaceuticals is supported by a highly experienced core management team with a proven track record of success. With a strong clinical and operational capability, the company aims to revolutionize the field of pharmaceuticals and improve patient outcomes.
Generated from the website